000 01195 a2200325 4500
005 20250517122623.0
264 0 _c20180510
008 201805s 0 0 chi d
022 _a1009-2137
024 7 _a10.7534/j.issn.1009-2137.2016.05.056
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aChen, Shao-Hua
245 0 0 _a[Immune Tolerance Mediated by TIM-3,LAG-3 and BTLA and Their Reversion in Hematological Malignancies-Review].
_h[electronic resource]
260 _bZhongguo shi yan xue ye xue za zhi
_cOct 2016
300 _a1594-1597 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAntigens, CD
650 0 4 _aHematologic Neoplasms
650 0 4 _aHepatitis A Virus Cellular Receptor 2
650 0 4 _aHumans
650 0 4 _aImmune Tolerance
650 0 4 _aImmunotherapy
650 0 4 _aReceptors, Immunologic
650 0 4 _aT-Lymphocytes
650 0 4 _aLymphocyte Activation Gene 3 Protein
700 1 _aZha, Xiang-Feng
700 1 _aLi, Yang-Qiu
773 0 _tZhongguo shi yan xue ye xue za zhi
_gvol. 24
_gno. 5
_gp. 1594-1597
856 4 0 _uhttps://doi.org/10.7534/j.issn.1009-2137.2016.05.056
_zAvailable from publisher's website
999 _c26552561
_d26552561